Skip Nav Destination

First Edition

Research Article December 19 2025

Hemoglobin A2 Levels in Indian Patients with Sickle Cell Disease Reveal Heterozygosity

Dinesh Pendharkar,Garima Nirmal

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Research Article December 19 2025

Urinary carbonic anhydrase 1 excretion is a marker of hemolysis-triggering conditions suitable for point-of-care testing

Alzbeta Hulikova,Zhenyi Wang,Helen Broomfield,Joanna Robinson,Miryam Healy,Rómulo J. Figueroa,Dionicia Gamboa,Katherine Torres,Gopal Ammanath,Deny Hartono,Richard C. Siow,Sara Engledow,Ketsanee Srinamon,Aniruddha Ghose,Katherine Plewes,Arjen M. Dondorp,Noemi BA Roy,Francisco C. Villafuerte,Hammad Khan,Pawel Swietach

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Research Article December 19 2025

Intensive induction for older AML patients in resource-constrained setting: insights from a Brazilian multicenter cohort

Frederico Lisboa Nogueira,Fernanda Rodrigues Mendes,Wellington Fernandes da Silva,Raphael Costa Bandeira de Melo,Camila Dermínio Donadel,Maria Isabel Ayrosa Madeira,Lorena Lôbo de Figueiredo Pontes,Robert Eduardo Emídio,Sandra Guerra Xavier,Ana Beatriz Firmato Glória,Evandro Maranhão Fagundes,Eduardo Magalhães Rego

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Brief Report December 15 2025

Poor outcomes of NPM1-mutated AML in Brazil despite traditional risks and recent adoption of molecular monitoring

Maria Victória Azevedo,Fernanda Mendes,Raphael de Melo,Luciana Nardinelli,Israel Bendit,Elvira Velloso,Vanderson Rocha,Eduardo Rego,Wellington Silva

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article November 17 2025

Baseline characteristics, treatment, and outcomes of indolent lymphoma in Malawi: a prospective, observational cohort

Tarsizious Chikaonda,Marriam Mponda,Bongani Kaimila,Edwards Kasonkanji,Maria Chikasema,Lusayo Simwinga,Noel Mumba,Richard Nyasosela,Maurice Mulenga,Tamiwe Tomoka,Satish Gopal,Yuri Fedoriw,Matthew S Painschab

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Research Article November 10 2025

HLA-B Leader Mismatch Predicts Increased GVHD Risk in Haploidentical Transplantation: Insights from a Latin American Cohort

Mauricio Sarmiento,Javier Diaz,Diego Gonzalez,Catherine Gutierrez,Veronica Jara,Patricio Rojas,Maria Garcia,Max Vergara,Felipe Palacios,Yorman Flores,Vicente Sandoval,Mauricio Ocqueteau,Francisco Barriga

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Research Article October 28 2025

“EXTENDED FAMILY SCREENING FOR THALASSEMIA TRAIT IN NORTH INDIA: EVALUATING POSSIBLE IMPACT AND IDENTIFYING BARRIERS”

Samneet Arora,Nishma Dhand,Khushi Goyal,Priyanka Dewan,Shruti Kakkar

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

First Edition

Hemoglobin A2 Levels in Indian Patients with Sickle Cell Disease Reveal Heterozygosity

Urinary carbonic anhydrase 1 excretion is a marker of hemolysis-triggering conditions suitable for point-of-care testing

Intensive induction for older AML patients in resource-constrained setting: insights from a Brazilian multicenter cohort

Poor outcomes of NPM1-mutated AML in Brazil despite traditional risks and recent adoption of molecular monitoring

Baseline characteristics, treatment, and outcomes of indolent lymphoma in Malawi: a prospective, observational cohort

HLA-B Leader Mismatch Predicts Increased GVHD Risk in Haploidentical Transplantation: Insights from a Latin American Cohort

“EXTENDED FAMILY SCREENING FOR THALASSEMIA TRAIT IN NORTH INDIA: EVALUATING POSSIBLE IMPACT AND IDENTIFYING BARRIERS”

ASH Publications

American Society of Hematology

First Edition

Hemoglobin A2 Levels in Indian Patients with Sickle Cell Disease Reveal Heterozygosity

Urinary carbonic anhydrase 1 excretion is a marker of hemolysis-triggering conditions suitable for point-of-care testing

Intensive induction for older AML patients in resource-constrained setting: insights from a Brazilian multicenter cohort

Poor outcomes of NPM1-mutated AML in Brazil despite traditional risks and recent adoption of molecular monitoring

Baseline characteristics, treatment, and outcomes of indolent lymphoma in Malawi: a prospective, observational cohort

HLA-B Leader Mismatch Predicts Increased GVHD Risk in Haploidentical Transplantation: Insights from a Latin American Cohort

“EXTENDED FAMILY SCREENING FOR THALASSEMIA TRAIT IN NORTH INDIA: EVALUATING POSSIBLE IMPACT AND IDENTIFYING BARRIERS”

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only